Combined with CD4/CD8 separation, our analyses now revealed that CD4+ and CD8+ T-cell repertoires in circulation of patients with advanced melanoma were restricted, with T-cell clones that were diversified in terms of Vβ-gene family and CDR3 length. Here, CD8A is linked to melanoma.